v3 Template
V

Vetigenics

Pet Biotechnology / Veterinary Medicine ~240 employees
Founded
--
Employees (Est.)
~240
12 leaders known
Total Funding
$6.0M
Funding Rounds
1
Last Funding
2025-02-03

About Vetigenics

Vetigenics is a pet biotech company dedicated to revolutionizing precision medicine for pets with cancer and chronic diseases through targeted antibody-based therapies. Founded in 2017, their mission is to transform personalized therapies for pets while advancing human medicine, with a focus on comparative oncology and enabling pets to live their best lives.

Products & Services

CANIBODY™ Platform:A proprietary canine phage display library with over 40 billion naturally occurring canine antibodies, used for developing antibody therapies for veterinary drug development without animal sacrifice.
Antibody-Based Therapies:Innovative therapies aimed at managing chronic diseases and cancer in pets, including clinical trials for dogs with cancer.

Specialties

Precision Medicine for Pets Antibody-Based Therapies Comparative Oncology Canine and Feline Immunotherapy Phage Display Technology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed 		A: 6000000
MR: -
FA: $6 million
FAN: 6000000 		D: 2025-02-03
FD: 2025-02-03 		-
Seed Latest
2025-02-03
$6.0M

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

N

Nicola Mason

Founder

D

Don Siegel

Founder

C

Chand Khanna

Board Member

S

Stephen Lesser

Board Member

C

Caleb Frankel

A

Adriann Sax

President, CEO and Founder

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Vetigenics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pet Biotechnology / Veterinary Medicine
Company Size
~240 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro